ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical Corporation

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors concerning the proposed acquisition of the company by Steris Plc (NYSE: STE) ("Steris"). Under the terms of the agreement, Cantel common stockholders will receive approximately $16.93 in cash and 0.33787 of a Steris ordinary share, or a total of value of approximately $84.66 per Cantel common share based on Steris's closing share price of $200.46 on January 11, 2021. The transaction is valued at approximately $4.6 billion and is expected to close by June 30, 2021.

If you are a stockholder of Cantel and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/cmd. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [e-mail], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. 

Attorney Advertising. Prior results do not guarantee a similar outcome.

 

View original content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-cantel-medical-corporation-301206774.html

SOURCE Rowley Law PLLC

Copyright 2021 PR Newswire